No Data
No Data
Why is Sunshine Power's performance “bucking the trend”? | Insight Research
The business structure is differentiated, and Sunshine Power is not affected by European inventories.
After all, it was the overseas market that saved Sunshine Power | Insight Research
Earnings in a single quarter reached a record high, and reliance on overseas has enabled Sunshine Power to achieve huge profits
Aligos Therapeutics Announced Friday A Research Collaboration And Development Agreement With Xiamen Amoytop Biotech Co. Ltd. For Use Of Aligos' Oligonucleotide Platform For Treatment Of Liver Diseases
Aligos Therapeutics and Xiamen Amoytop Biotech Join Hands for the Treatment of Liver Diseases
Zhongji Innolight Nets $416 Million From Private Share Sale
Sungrow Power's Valuation Looks Demanding to Daiwa -- Market Talk